 |
 |
> > Even though Eldepryl (Deprenyl, selegiline) is mentioned by authorities, > it has been debated among them for years. Last December there was an > alarming report claiming not only that Eldepryl is ineffective, but that > it seemed to shorten the statistical lifespan of the rather elderly > study subjects. Understandably, neurologists hesitate now to recommend > it, but the conventional wisdom seems to be, wait and see; if you are > already using it and it seems to help, continue at least until the > adverse reports are confirmed. You can always quit if the benefit > doesn't outweigh the apparent cost. > Cheers, Joe > My husband has been taking Eldepryl of years. One of the first benefits he received from the drug was a good night's sleep. After reading about the potential danger of Eldepryl, he cut back on his dosage and now has difficulty sleeping again. I appreciate the importance of this study, however I have to wonder if there was a distinction made between YOP and Parkinsons acquired after the age of 60. It may be that Eldepryl benefits a younger population while contributing to mortality in an older population. ------ Regards Mary Ann